Tofacitinib for rheumatoid arthritis

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the benefits and harms of tofacitinib for the treatment of rheumatoid arthritis. Our PICO question is as follows: Population: Adult patients with rheumatoid arthritis. Intervention: Tofacitinib alone or combined with any DMARD. Comparison: Placebo or DMARD. Outcomes: Efficacy, radiographic, patient-reported and safety outcomes.




Lopez-Olivo, M. A., Bavineni, M., & Suarez-Almazor, M. E. (2013). Tofacitinib for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2013(4).

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free